Vincerx Pharma, Inc.
VINC
$0.0504
-$0.0096-16.00%
OTC PK
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
4/17/2025
-
GuruFocus
4/17/2025
-
The Fly
4/17/2025
-
Globe Newswire
4/11/2025
-
TipRanks Financial Blog
4/9/2025
-
FierceBiotech.com - Biotech
4/8/2025
-
GuruFocus
4/8/2025
-
GuruFocus
4/8/2025
-
TipRanks Financial Blog
4/8/2025
-
The Fly
4/8/2025
-
TipRanks Financial Blog
4/8/2025
-
Globe Newswire
4/8/2025
-
The Fly
3/18/2025
-
Seeking Alpha - Healthcare
3/18/2025
-
GuruFocus
3/18/2025
-
The Fly
3/18/2025
-
TipRanks Financial Blog
3/18/2025
-
The Fly
3/18/2025
-
Globe Newswire
3/18/2025
-
The Fly
2/28/2025
-
GuruFocus
2/28/2025
-
The Fly
2/28/2025
-
TipRanks Financial Blog
2/28/2025
-
Seeking Alpha - Healthcare
2/28/2025
-
TipRanks Financial Blog
2/28/2025
-
The Fly
Income Statement
Total Revenue (TTM)
--
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Thursday, March 27, 2025
Period Date
Tuesday, December 31, 2024
Next Filing
Week of May 12 and 16 (est)
Price History
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
--
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
--
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
650 800 6676
Address
1825 S. Grant Street
San Mateo, CA 94402
San Mateo, CA 94402
Country
Year Founded
Business Description
Sector
Vincerx Pharma, Inc. operates as a clinical-stage biopharmaceutical company that develops differentiated and novel therapies to address the unmet medical needs of patients with cancer in the...
more